# Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

> **NCT03060356** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 77 (actual)

## Conditions studied

- Malignant Melanoma
- Breast Cancer

## Interventions

- **BIOLOGICAL:** T cells modified with RNA anti -cMET CAR

## Key facts

- **NCT ID:** NCT03060356
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-21
- **Primary completion:** 2020-03-27
- **Final completion:** 2020-03-27
- **Target enrollment:** 77 (ACTUAL)
- **Why stopped:** Halt in funding
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03060356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03060356, "Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03060356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*